Blue Biofuels, Inc. (BIOF) Fair Value 2026

BIOF · Specialty Chemicals ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.1 /10

32 fundamental signals · 1 models active

Value Trap Risk

LOW (26/100)

Quick Summary — As of 2026-08-27, Blue Biofuels, Inc. (BIOF) trades at $0.10. QOC: 4.1/10. Value Trap Risk: 26/100 (LOW). 1/13 models active.

Key Facts

Ticker
BIOF
Price
$0.10
Quality Score
4.1/10
Value Trap Risk
26/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.1/10 signals weak fundamentals

What Fair Value Does Each Model Give BIOF?

1 Intrinsic Value Models vs. Current Price ($0.10)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · High Conviction
 $0.01 -92.7%

All Models Active

All 1 models are displayed above.

What Is Blue Biofuels, Inc. (BIOF) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Blue Biofuels, Inc.'s intrinsic value is estimated at $0.01. Trading at its current price of $0.11, the valuation engine raises significant caution: 1 of 1 models flag downside risk, projecting a median implied return of -92.7%.

What Do the Models Say About BIOF?

1 of 13 models are currently active for BIOF. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does BIOF Rank in Specialty Chemicals?

Among 69 Specialty Chemicals stocks, BIOF ranks #63 by Quality of Company score. CirclFi's QOC score of 4.1/10 evaluates 32 fundamental signals. A score of 4.1 reflects mixed fundamentals.

See all Most Undervalued Specialty Chemicals Stocks →

The Specialty Chemicals sector introduces analytical considerations specific to industrial businesses. For Blue Biofuels, Inc., metrics like book-to-bill ratio provide important context that general-purpose valuation models may underweight.

Is BIOF a Value Trap?

CirclFi's Value Trap algorithm assigns BIOF a score of 26/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Blue Biofuels, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Blue Biofuels, Inc. scores 4.1 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every BIOF valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across BIOF's 1 active models, average confidence is 52%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Blue Biofuels, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Specialty Chemicals Stocks Should You Also Analyze?

11 related Specialty Chemicals stocks with 13-model coverage

HGASGlobal Gas CorporationQOC 4.2QGAIQuantum Genesis AI Corp.QOC 3.9FEAV5E Advanced Materials, Inc.QOC 4.2YMATJ-Star Holding Co., Ltd.QOC 3.1KBLBKraig Biocraft Laboratories, Inc.QOC 4.4SQMSociedad Química y Minera de Chile S.A.QOC 2.7AXTAAxalta Coating Systems Ltd.QOC 8.6MTXMinerals Technologies Inc.QOC 7.2ECVTEcovyst Inc.QOC 6.3ODCOil-Dri Corporation of AmericaQOC 9.2RPMRPM International Inc.QOC 9.0

Read investment analysis: HGAS · QGAI · FEAV · YMAT · KBLB · SQM · AXTA · MTX · ECVT · ODC · RPM

Which Other Stocks Have a Similar Quality Score to BIOF?

7 companies across all industries closest to BIOF’s Quality of Company score of 4.1/10.

IMOImperial Oil LimitedQOC 4.1ARMPArmata Pharmaceuticals, Inc.QOC 4.1RAINRain Enhancement Technologies Holdco, Inc.QOC 4.1GRPSGold River Productions, Inc.QOC 4.1CONCConectiSys CorporationQOC 4.1DBMMDigital Brand Media & Marketing Group, Inc.QOC 4.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: IMO · ARMP · RAIN · GRPS · CONC · DBMM · NVDA

Where Does BIOF Sit in CirclFi's Specialty Chemicals Rankings?

BIOF is ranked against every other Specialty Chemicals stock CirclFi covers in each of these screens.

See all Specialty Chemicals stocks ranked →

What Else Do Investors Ask About Blue Biofuels, Inc.’s Valuation?

What is Blue Biofuels, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Blue Biofuels, Inc. (BIOF). The Quality of Company score is 4.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is BIOF overvalued or undervalued right now?

At $0.10, 0 of 1 active models suggest BIOF may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits Blue Biofuels, Inc.'s business model in Specialty Chemicals.

What does a Quality of Company score of 4.1 mean for BIOF?

Blue Biofuels, Inc.'s QOC of 4.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on BIOF?

CirclFi analyzes BIOF with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is BIOF a value trap in 2026?

Blue Biofuels, Inc.'s Value Trap score is 26/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Blue Biofuels, Inc. (BIOF) a Quality of Company score of 4.1/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/BIOF/ · Methodology
Primary sources for this BIOF valuation
  • Financial statements: Blue Biofuels, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001549145) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for BIOF as of ; valuations recomputed .